Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Johnson & Johnson to Invest over US$1 Billion in Pennsylvania, USA
Johnson Johnson has announced an investment of over US$1 billion to develop a nextgeneration cell therapy manufacturing facility in Montgomery County, Pennsylvania, USA The development will support the production of advanced cell therapies used in the treatment of cancer
FUJIFILM Biotechnologies to Invest US$500 Million (£400 Million) in Teesside, United Kingdom
FUJIFILM Biotechnologies has announced an investment of approximately US$500 million 400 million to expand its biomanufacturing and process development facilities in Teesside, United Kingdom The development involves the expansion of biomanufacturing and process development facilities to support
Eli Lilly to Invest over US$3.5 Billion in Pennsylvania, USA
Eli Lilly and Company has announced plans to invest more than US$35 billion in a new injectable medicine and device manufacturing facility in Lehigh Valley, Pennsylvania, USA The development involves the construction of an injectable medicine and device manufacturing facility to support
Axplora to Invest US$35 Million (€30 Million) in Le Mans, France
Axplora has announced a US$35 million 30 million investment to expand lyophilisation capabilities at its facility in Le Mans, France The development involves the expansion of lyophilisation capacity at an existing pharmaceutical manufacturing facility, supporting the freezedrying of materials
BD to Expand its Manufacturing Site in Columbus, USA
BD Becton, Dickinson and Company has announced plans to invest US$110 million to expand production of prefillable syringes at its manufacturing site in Columbus
Novartis to Invest US$23 Billion in Florida, USA
Novartis has announced plans to invest US$23 billion to build a radioligand therapy manufacturing facility in Winter Park
Genentech to Invest US$2 Billion in North Carolina, USA
Genentech has announced plans to invest approximately US$2 billion to expand its manufacturing facility in Holly Springs, North Carolina, USA
Sharp Sterile Manufacturing to Invest US$28 Million to Expand Facility in Massachusetts, USA
Sharp Sterile Manufacturing has announced plans to invest US$28 million to expand its facility in Lee, Massachusetts, USA
Alnylam to Invest US$250 Million to Expand RNAi Manufacturing Facility in Massachusetts, USA
Alnylam Pharmaceuticals has announced plans to invest US$250 million to expand its manufacturing facility in Norton, Massachusetts, USA
Samsung Biologics to Invest US$280 Million to Expand Biologics Manufacturing in Maryland
Samsung Biologics has announced plans to invest US$280 million to acquire a biologics manufacturing facility in Rockville, Maryland, USA The Rockville site includes two cGMP manufacturing plants with a combined capacity of 60,000 litres, supporting both clinical and commercial production
